/ FDA
/ Market Analysis
Vanda (VNDA) Stock Skyrockets on FDA Approval for Bipolar, Schizophrenia Drug
Vanda stock jumped more than 40% in premarket trading after the FDA approved its new drug BYSANTI for Bipolar I disorder and schizophrenia.
February 23, 2026
Why Is Moderna (MRNA) Stock Down Premarket? FDA Rejects Flu Vaccine Filing
Moderna stock dropped over 9% in premarket trading after the FDA refused to review its mRNA-based flu vaccine, citing inadequate study design.
February 11, 2026
Novo Nordisk Shares Rise After FDA Pressures Hims to Pull Weight-Loss Pill
Novo Nordisk stock jumped 8% after Hims & Hers withdrew its knockoff Wegovy pill amid FDA scrutiny and legal threats.
February 09, 2026
Why Is Novo Nordisk Stock Popping in Premarket? Wegovy Pill Wins FDA Approval
Novo Nordisk shares rose more than 7% in premarket trading after the FDA approved its oral Wegovy weight-loss pill.
December 23, 2025
Moderna Stock Drops as FDA Signals New Restrictions on Vaccine Approvals
Moderna shares fell over 4% after the FDA signaled stricter vaccine approval rules, raising concerns about potential delays for new vaccines.
December 01, 2025More from The Tokenist / FDA
Why Did Outlook Therapeutics (OTLK) Shares Crash Today?
August 28, 2025
Back to 
